Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by Landroon Apr 15, 2010 10:48am
322 Views
Post# 16994771

RE: RE: Management

RE: RE: ManagementManagement listens to the experts they hire...

I am sure glad that they hired such a top-notch PR expert to fully leverage the FDA approval back in November....where would we be now if they had left that to clueless amateurs...
I also think that the expert they use to engineer their reorganization of December 1st can only be a giant in the field of organizational management...with two CEO's, we will surely obtain twice the returns. Those who question this incredibly clever move are just naysayers who knows nothing about management...
Nuvo's and Covidien logistics experts should also be highly praised...I am still awed by the the fact that it will have taken ONLY nine months  between the FDA approval and the launch in the US....I am convinced that this delay could have been measured in YEARS without the contribution of these logistics experts....
Finally, having dealt personally with their investor relations expert Mr. Peeler last summer, I was completely taken by his proactive approach, his willingness to answers pointed questions and is great availability: imagine, it only took two emails and two voice mail on my part to talk to him. Some naysayers would see this negatively but I sure don't considering what he brings to the table....such experts are extremely busy!

Considering all this, I just changed my mind regarding the RS...they should even go further and do a 4000-1 rs...with 100,000 shares valued at $1000 each, we could forget about the measly NASDAQ and go directly to the NYSE ...from there, our experts CEO's will bring us riches that will make Buffet look like an amateur....


Bullboard Posts